Back to Search
MURTAZA HUSSAIN, MD
MD
Internal Medicine Physician
NPI: 1043238421Individual
Specialties, Licenses & Credentials
Research & Publications (20)
A phase II study of rebeccamycin analog (NSC-655649) in metastatic renal cell cancer.
PMID 14586215·Invest New Drugs·2003
3-trial
Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locallyadvanced prostate cancer.
PMID 12670564·Urology·2003
3-trial
Novel gemcitabine-containing triplets in the management of urothelial cancer.
PMID 11894004·Semin Oncol·2002
6-review
Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group Study.
PMID 11125363·J Urol·2001
3-trial
Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer.
PMID 11331332·J Clin Oncol·2001
8-other
Androgen deprivation and four courses of fixed-schedule suramin treatment in patients with newly diagnosed metastatic prostate cancer: A Southwest Oncology Group Study.
PMID 10694555·J Clin Oncol·2000
3-trial
Dimethyltin(IV) derivatives of biologically potent substituted phenylacrylic acids: synthesis, chemical characterization and inhibitory effects on Agrobacterium tumefaciens.
PMID 19573076·Chem Biol Drug Des·2009
8-other
TIPS for the examination of flexor digitorum superficialis.
PMID 19217365·J Plast Reconstr Aesthet Surg·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 18254 LIVERNOIS AVE
DETROIT, MI 48221 - Phone
- (313) 861-4400
Quick Facts
- NPI
- 1043238421
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile